Science2 hours ago
Dyne Therapeutics Moves Toward Approval for Duchenne Drug
Dyne Therapeutics announced on Monday that its experimental drug targeting Duchenne muscular dystrophy (DMD) has successfully met its primary endpoint in a late-stage clinical trial. This...